financetom
Business
financetom
/
Business
/
Scotts Miracle-Gro Names Nate Baxter President, CEO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Scotts Miracle-Gro Names Nate Baxter President, CEO
Jun 29, 2026 4:42 AM

07:20 AM EDT, 06/29/2026 (MT Newswires) -- Scotts Miracle-Gro ( SMG ) said Monday it has named Nate Baxter president and chief executive officer, as well as a member of the company's board of directors, effective immediately.

Baxter succeeds Jim Hagedorn, who had been CEO since 2001 and chairman since 2003.

The company also said that it has elected Independent Lead Director Pete Shumlin as chairman.

Shares of Scotts Miracle-Gro ( SMG ) were down 2.1% pre-bell.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Intuitive Surgical Insider Sold Shares Worth $435,000, According to a Recent SEC Filing
Nov 13, 2025
01:58 PM EST, 11/13/2025 (MT Newswires) -- Craig H Barratt, Director, on November 12, 2025, sold 750 shares in Intuitive Surgical ( ISRG ) for $435,000. Following the Form 4 filing with the SEC, Barratt has control over a total of 27,198 common shares of the company, with 27,198 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1035267/000127762025000008/xslF345X05/edgardoc.xml Price: 568.86, Change: -3.60, Percent Change:...
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Gilead's One-Pill HIV Treatment Shows Promise In Late-Stage Trial
Nov 13, 2025
Gilead Sciences Inc ( GILD ). on Thursday shared topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the treatment responses of HIV patients who are virologically suppressed switching from a multi-tablet regimen to an investigational single-tablet regimen of bictegravir 75 mg/lenacapavir 50 mg (BIC/LEN). • GILD shares are testing new highs. Check the market position here....
Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M
Turning Vision Into Value: Cie Portfolio Win as Nativo Is Acquired for $120M
Nov 13, 2025
IRVINE, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cie, a venture studio, announced today that its portfolio company Nativo, a leading advertising technology provider, has entered into a definitive agreement to be acquired by Life360 ( LIF ) . The transaction, valued at approximately $120 million in cash and stock, marks another successful outcome of Cie’s venture studio model. Nativo joins...
Serve Robotics Shares Skid: What's Going On?
Serve Robotics Shares Skid: What's Going On?
Nov 13, 2025
Serve Robotics Inc ( SERV ) shares are trading lower on Thursday. The company disclosed its financial results for the third quarter. SERV is underperforming relative to peers. Get the market research here. What To Know: Serve Robotics ( SERV ) reported quarterly losses of 40 cents per share, versus the analyst consensus estimate for losses of 33 cents per share....
Copyright 2023-2026 - www.financetom.com All Rights Reserved